He Cui
Biographic Data
| ID | 7187015 |
|---|---|
| NAME | He Cui |
| GIVEN NAMES | He |
| FAMILY NAME | Cui |
| SIGNATURE | CUI H |
| AFFILIATIONS | China Medical University |
| ORCID | 0000-0001-6277-9804 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Engeletin attenuates the inflammatory response via inhibiting TLR4-NFκB signaling pathway in Crohn's disease-like colitis
ENG has been proven to alleviate inflammation and ameliorate the damage of epithelial barrier in CD-like colitis. ENG also suppressed the M1 macrophages polarization and the inhibited inflammatory cytokines. TLR4-NFκB signaling pathway, especially TLR4, may be the target of ENG. These data offer a new insight into the therapeutic mechanisms of ENG
No prominent works on this page.
Engeletin attenuates the inflammatory response via inhibiting TLR4-NFκB signaling pathway in Crohn's disease-like colitis
ENG has been proven to alleviate inflammation and ameliorate the damage of epithelial barrier in CD-like colitis. ENG also suppressed the M1 macrophages polarization and the inhibited inflammatory cytokines. TLR4-NFκB signaling pathway, especially TLR4, may be the target of ENG. These data offer a new insight into the therapeutic mechanisms of ENG
Colitis (1 work) · Crohn's disease (1 work) · Disease (1 work) · IL-33, ST2, and ILC Pathways (1 work) · Immune Response and Inflammation (1 work) · Immunology (1 work) · Inflammation (1 work) · Inflammatory Bowel Disease (1 work) · Inflammatory response (1 work) · Internal Medicine (1 work)